Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

Korábbi kezelés

• Previous treatment for AML other than hydroxyurea;

Más betegség

• Presence of positive virological markers indicating active infection (hepatitis B, hepatitis C, or HIV).
• Diagnosis of a hematologic disease other than AML;
• Presence of positive virological markers indicating active infection (hepatitis B, hepatitis C, or HIV);

Egyéb

• Patients deemed unsuitable for sampling by the surgeon performing the procedure;
• Patients under legal protection measures;
• Patients under judicial supervision or deprived of liberty by judicial or administrative decision;
• / AML Group
• Clinical signs suggestive of active central nervous system leukemia, or presence of isolated extramedullary leukemia;
• Severe comorbidities that could interfere with the study, as assessed by the principal investigator;
• Patients under legal protection;
• Patients under judicial supervision or deprived of liberty by judicial or administrative decision.

• Age ≥ 60 years;
• Scheduled for cardiac surgery involving sternotomy;
• Normal blood count within the two months preceding sampling;
• Affiliated with, or beneficiary of, a social security system;
• Written informed consent to participate in the study.
• Age ≥ 60 years;
• Diagnosis of de novo AML or AML secondary to myelodysplastic syndrome, scheduled to receive azacitidine-based treatment;
• Affiliated with, or beneficiary of, a social security system;
• Written informed consent to participate in the study.

A regiszterben nem jelölt feltételek

• / Control Group